Successful Treatment with Crizotinib in Mechanically Ventilated Patients with ALK Positive Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Successful Treatment with Crizotinib in Mechanically Ventilated Patients with ALK Positive Non–Small-Cell Lung Cancer

Published:2013-02 Issue:2 Volume:8 Page:250-253
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ahn Hee Kyung,Jeon Kyeongman,Yoo Hongseok,Han Boram,Lee Su Jin,Park Hyeyon,Lee Min Ji,Ha Sang Yun,Han Joung Ho,Sun Jong-Mu,Ahn Jin Seok,Ahn Myung-Ju,Park Keunchil

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference7 articles.

1. The outcome of medical intensive care for lung cancer patients: the case for optimism;Soubani;Journal of thoracic oncology,2011

2. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit;Adam;The European respiratory journal,2008

3. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;The New England journal of medicine,2010

4. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit;Benoit;Intensive Care Med,2006

5. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy;Darmon;Critical care medicine,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report;Oncotarget;2024-01-16

2. Tratamiento exitoso con alectinib administrado por sonda nasogástrica en adenocarcinoma de pulmón avanzado ALK-positivo en ventilación mecánica: reporte de caso;Acta Colombiana de Cuidado Intensivo;2023-07

3. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma;BMC Cancer;2021-07-23

4. Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors;JTO Clinical and Research Reports;2021-04

5. Initiation of a new anti-cancer medical treatment in ICU: a retrospective study;Acta Clinica Belgica;2021-01-08